Aiming at Neuroblastoma and Hitting Other Worthy Targets

Schor, Nina F.
June 2013
Journal of Child Neurology;Jun2013, Vol. 28 Issue 6, p765
Academic Journal
Neuroblastoma is, at once, the most common and deadly extracranial solid tumor of childhood. Efforts aimed at targeting the neural characteristics of these tumors have taught us much about neural crest cell biology, apoptosis induction in the nervous system, and neurotrophin receptor signaling and intracellular processing. But neuroblastoma remains a formidable enemy to the oncologist and an enigmatic target to the neuroscientist.


Related Articles

  • Constitutively active TrkB confers an aggressive transformed phenotype to a neural crest-derived cell line. DeWitt, J; Ochoa, V; Urschitz, J; Elston, M; Moisyadi, S; Nishi, R // Oncogene;2/20/2014, Vol. 33 Issue 8, p977 

    Neuroblastoma arises from sympathoadrenal progenitors of the neural crest and expression of the neurotrophin receptor TrkB and its ligand, brain-derived neurotrophic factor (BDNF), is correlated with poor prognosis. Although activated TrkB signaling promotes a more aggressive phenotype in...

  • In Situ Neuroblastoma: An Important Concept Related to the Natural History of Neural Crest Tumors. Shimada, Hiroyuki // Pediatric & Developmental Pathology;May/Jun2005, Vol. 8 Issue 3, p305 

    Since the initial description of the entity known as “ in situ neuroblastoma,” thoughts about the origin, fate, and clinical significance of this anatomic finding have influenced the field of neuroectodermal tumor biology. This paper discusses the importance of the original...

  • p75NTR: an enhancer of fenretinide toxicity in neuroblastoma. Ganeshan, Veena; Ashton, John; Schor, Nina // Cancer Chemotherapy & Pharmacology;Mar2013, Vol. 71 Issue 3, p777 

    Objective: Neuroblastoma is a common, frequently fatal, neural crest tumor of childhood. Chemotherapy-resistant neuroblastoma cells typically have Schwann cell-like ('S-type') morphology and express the p75 neurotrophin receptor (p75NTR). p75NTR has been previously shown to modulate the redox...

  • The conundrum posed by cellular heterogeneity in analysis of human neuroblastoma. Ross, Robert A.; Spengler, Barbara A. // JNCI: Journal of the National Cancer Institute;8/18/2004, Vol. 96 Issue 16, p1192 

    Editorial. Discusses the conundrum posed by cellular heterogeneity in the analysis of human neuroblastoma. Role of examination of methylation patterns and gene promoters in identification of different tumor subtypes; Silencing of gene expression by DNA methylation; Separation of cell lines into...

  • BBC3 mediates fenretinide-induced cell death in neuroblastoma. Wei, Jun S.; Whiteford, Craig C.; Cenacchi, Nicola; Chang Gue Son; Khan, Javed // Oncogene;12/1/2005, Vol. 24 Issue 54, p7976 

    Fenretinide (4-HPR) is a synthetic retinoid whose apoptosis-inducing effects have been demonstrated in many tumor types. The precise mechanism of its apoptotic action is not fully understood. To further study the mechanism by which 4-HPR exerts its biological effects in neuroblastoma (NB) and to...

  • Rare coexistence of metastatic neuroblastoma of liver and solid pseudo papillary tumor of pancreas: Case report and literature review. Jiao Zhang; Yinghua Liu; Pingqian Bao; Yi Wang; Yi Zhang; Yuan Li // Journal of Cancer Research & Therapeutics;Apr-Jun2013, Vol. 9 Issue 2, p308 

    Neuroblastoma is the second most common malignant solid tumor in children, and often metastasizes to liver, most notably in patients with stage 4S tumors. Solid pseudopapillary tumor of the pancreas (SPT) is a pancreatic borderline tumor with low malignant potential. Coexistence of these two...

  • p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma. Ganeshan, Veena; Schor, Nina // Cancer Chemotherapy & Pharmacology;Feb2014, Vol. 73 Issue 2, p271 

    Purpose: Neuroblastoma is the most common extracranial solid tumor of childhood. The retinoic acid analogue, fenretinide (4-hydroxyphenyl retinamide; 4-HPR), induces apoptosis in neuroblastoma cells in vitro and is currently in clinical trials for children with refractory neuroblastoma. We have...

  • Reflections on the neural crest. Thomson, Keith Stewart // American Scientist;Jan/Feb83, Vol. 71 Issue 1, p72 

    Focuses on neural crest. Fascinating aspect of ten neural crest and epidermal placodes; Functions of the neural crest; Difficulty in working with the neural crest.

  • Expression of Inhibitor-of-Apoptosis Protein (IAP) Livin by Neuroblastoma Cells: Correlation with Prognostic Factors and Outcome. Dae-Kwang Kim; Alvarado, Carlos S.; Abramowsky, Carlos R.; Lubing Gu; Muxiang Zhou; Minn-Minn Soe; Sullivan, Kevin; George, Bradley; Schemankewitz, Erwin; Findley, Harry W. // Pediatric & Developmental Pathology;Nov/Dec2005, Vol. 8 Issue 6, p621 

    Livin is a recently identified member of the Inhibitor-of-Apoptosis protein (IAP) family of antiapoptosis proteins, and expression has been reported in melanoma and some types of carcinoma. We evaluated livin expression in paraffin-embedded tumor tissue from 68 patients with neuroblastoma (NB)...


Read the Article


Sign out of this library

Other Topics